Anti-novel coronavirus drug under clinical trial: official

2020-02-04 03:22:19 GMT2020-02-04 11:22:19(Beijing Time) 菲律宾申博在线代理开户登入

BEIJING, Feb. 3 (Xinhua) -- Multiple medical institutions are conducting clinical trials for the anti-novel coronavirus drug Remdesivir, Chinese health authorities said Monday.

The clinical trials are aimed to study the safety and effectiveness of the drug, said Song Shuli, spokesperson for the National Health Commission (NHC), at a press conference.

Information and data of clinical trials for Lopinavir and Ritonavir and traditional Chinese medicines are being collected, Song said.

The NHC has issued a trial plan for the diagnosis and treatment of pneumonia caused by the novel coronavirus, Song said, adding that the plan offers detailed information of the medicines, both traditional Chinese medicines and western medicines, used in the treatment of the disease.

All documents released by the NHC are available on its official website, Song said.

| PRINT | RSS
网站地图 百家乐真人游戏 申博登录网址 申博游戏下载 申博开户
申博游戏登录官网 申博娱乐登入 申博手机投注 太阳城菲律宾官网申博登入
申博登入网址 盛618网址 百家乐 太阳城登入
星级百家乐 盛618登入 百家乐登入网址 申博会员登入
澳门银河赌场 幸运大转盘 申博官网 申博现金百家乐